Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome

Haematologica

Volumn 101, Issue 6, 2016, Pages 707-716

  Nováková, Michaela ^a   Žaliová, Markéta ^a   Suková, Martina ^a   Wlodarski, Marcin ^b   Janda, Aleš ^b   Froňková, Eva ^a   Campr, Vít ^a   Lejhancová, Kateřina ^c   Zapletal, Ondřej ^d   Pospíšilová, Dagmar ^e   Černá, Zdeňka ^f   Kuhn, Tomáš ^g   Švec, Peter ^h   Pelková, Vendula ^a   Zemanová, Zuzana ⁱ   Kerndrup, Gitte ^j   van den Heuvel Eibrink, Marry ^k   van der Velden, Vincent ^l   Niemeyer, Charlotte ^b   Kalina, Tomáš ^a   Trka, Jan ^a   Starý, Jan ^a   Hrušák, Ondřej ^a   Mejstříková, Ester ^a   more..

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^d MASARYK UNIVERSITY   (Czech Republic)

^e PALACKÝ UNIVERSITY   (Czech Republic)

^f CHARLES UNIVERSITY   (Czech Republic)

^g UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^h UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

ⁱ CHARLES UNIVERSITY   (Czech Republic)

^j AARHUS UNIVERSITY HOSPITAL   (Denmark)

^k Department of Radiation Oncology   (Netherlands)

^l ERASMUS MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD19 ANTIGEN; CD20 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; GENOMIC DNA; MICROSOMAL AMINOPEPTIDASE; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR GATA 2; BIOLOGICAL MARKER;

ABSOLUTE NEUTROPHIL COUNT; ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; BONE MARROW; CELL LOSS; CELL POPULATION; CHILD; CHROMOSOME ABERRATION; COHORT ANALYSIS; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENE; GENE SEQUENCE; HUMAN; IMMUNOPHENOTYPING; LYMPHOCYTOPENIA; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MONOSOMY 7; MUTATION; MYELODYSPLASTIC SYNDROME; NATURAL KILLER CELL; NEUTROPHIL COUNT; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; REFRACTORY CYTOPENIA; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTOR GATA 2 GENE; TRISOMY 8; YOUNG ADULT; ANEMIA, APLASTIC; BONE MARROW CELL; DEFICIENCY; DIFFERENTIAL DIAGNOSIS; GENETICS; IMMUNOLOGY; INFANT; LYMPHOCYTE COUNT; LYMPHOPENIA; METABOLISM; MYELODYSPLASTIC SYNDROMES; PATHOLOGY; PHENOTYPE; PRE B LYMPHOCYTE; PRESCHOOL CHILD; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ANEMIA, APLASTIC; B-LYMPHOCYTES; BIOMARKERS; BONE MARROW; BONE MARROW CELLS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; GATA2 TRANSCRIPTION FACTOR; HUMANS; IMMUNOPHENOTYPING; INFANT; LYMPHOCYTE COUNT; LYMPHOPENIA; MUTATION; MYELODYSPLASTIC SYNDROMES; MYELOID CELLS; PHENOTYPE; PRECURSOR CELLS, B-LYMPHOID; ROC CURVE; T-LYMPHOCYTE SUBSETS; YOUNG ADULT;

EID: 84971578103     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2015.137711     Document Type: Article

References (35)

1. Hasle H, Wadsworth LD, Massing BG, McBride M, Schultz KR. A populationbased study of childhood myelodysplastic syndrome in British Columbia, Canada. Br J Haematol. 1999;106(4):1027-1032.
2. Baumann I, Niemeyer CM, Bennett JM, Shannon K. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: International Agency of Research on Cancer (IARC); 2008. p 104-107.
3. Baumann I, Führer M, Behrendt S, et al. Morphological differentiation of severe aplastic anaemia from hypocellular refractory cytopenia of childhood: reproducibility of histopathological diagnostic criteria. Histopathology. 2012;61(1):10-17.
4. Strahm B, Nöllke P, Zecca M, et al. Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study. Leukemia. 2011;25(3):455-462.
5. Shimamura A, Alter BP. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev. 2010; 24(3):101-122.
6. Ostergaard P, Simpson MA, Connell FC, et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet. 2011;43(10):929-931.
7. Dickinson RE, Griffin H, Bigley V, et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood. 2011;118(10):2656-2658.
8. Hahn CN, Chong C-E, Carmichael CL, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011;43(10):1012-1017.
9. Hsu AP, Johnson KD, Falcone EL, et al. GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome. Blood. 2013;121(19):3830-3837, S1-S7.
10. Ganapathi KA, Townsley DM, Hsu AP, et al. GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia. Blood. 2015;125(1):56-70.
11. Dickinson RE, Milne P, Jardine L, et al. The evolution of cellular deficiency in GATA2 mutation. Blood. 2014;123(6):863-874.
12. Calvo KR, Vinh DC, Maric I, et al. Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications. Haematologica. 2011; 96(8):1221-1225.
13. Hirabayashi S, Strahm B, Urbaniak S, et al. Unexpected High Frequency of GATA2 Mutations in Children with Non-Familial MDS and Monosomy 7. ASH Annual Meeting Abstracts. 2012;120(21):1699.
14. Westers TM, Ireland R, Kern W, et al. Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group. Leukemia. 2012;26(7):1730-1741.
15. Della Porta MG, Picone C, Pascutto C, et al. Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European Leukemia NET study. Haematologica. 2012;97(8):1209-1217.
16. van de Loosdrecht AA, Westers TM, Westra AH, et al. Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry. Blood. 2008;111(3):1067-1077.
17. Aalbers AM, van den Heuvel-Eibrink MM, de Haas V, et al. Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood. Leukemia. 2013;27(9):1923-1925.
18. Aalbers AM, van den Heuvel-Eibrink MM, Baumann I, et al. Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood. Haematologica. 2015;100(3):315-323.
19. van Zelm MC, Szczepanski T, van der Burg M, van Dongen JJM. Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J Exp Med. 2007;204(3):645-655.
20. Weinberg K, Blazar BR, Wagner JE, et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood. 2001;97(5):1458-1466.
21. Fronková E, Klocperk A, Svatoñ M, et al. The TREC/KREC assay for the diagnosis and monitoring of patients with DiGeorge syndrome. PLoS One. 2014;9(12):e114514.
22. Fronkova E, Muzikova K, Mejstrikova E, et al. B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL. Bone Marrow Transplant. 2008;42(3):187-196.
23. Veltroni M, Sainati L, Zecca M, et al. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool? Pediatr Blood Cancer. 2009;52(3):357-363.
24. Bras AE, van den Heuvel-Eibrink MM, van der Sluijs-Gelling AJ, et al. No significant prognostic value of normal precursor B-cell regeneration in paediatric acute myeloid leukaemia after induction treatment. Br J Haematol. 2013;161(6):861-864.
25. Piatosa B, Wolska-Kušnierz B, Pac M, et al. B cell subsets in healthy children: reference values for evaluation of B cell maturation process in peripheral blood. Cytometry B Clin Cytom. 2010;78(6):372-381.
26. Svobodova T, Mejstrikova E, Salzer U, et al. Diffuse parenchymal lung disease as first clinical manifestation of GATA-2 deficiency in childhood. BMC Pulm Med. 2015;15:8.
27. Chou J, Lutskiy M, Tsitsikov E, et al. Presence of hypogammaglobulinemia and abnormal antibody responses in GATA2 deficiency. J Allergy Clin Immunol. 2014; 134(1):223-226.
28. Spinner MA, Sanchez LA, Hsu AP, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2014;123(6):809-821.
29. Dotta L, Badolato R. Primary immunodeficiencies appearing as combined lymphopenia, neutropenia, and monocytopenia. Immunol Lett. 2014;161(2):222-225.
30. Pasquet M, Bellanné-Chantelot C, Tavitian S, et al. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Blood. 2013;121(5):822-829.
31. Mejstrikova E, Pelkova V, Reiterova M, et al. Composition of Cellular Subsets by Flow Cytometry Identifies Differences Between MDS Subtypes and Aplastic Anemia but No Differences Are Identified Between Cases with and without Monosomy 7. ASH Annual Meeting Abstracts. 2009;114(22):3802.
32. Reiterova M, Kramarzova K, Sukova M, et al. Changes Identified by Flow Cytometry and WT1 Expression in Consecutive Bone Marrow Samples in Refractory Cytopenia of Childhood and Aplastic Anemia Before Start of the Therapy. ASH Annual Meeting Abstracts. 2011;118(21):1342.
33. Yoshimi A, van den Heuvel-Eibrink MM, Baumann I, et al. Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood. Haematologica. 2014; 99(4):656-663.
34. Führer M, Rampf U, Baumann I, et al. Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. Blood. 2005; 106(6):2102-2104.
35. Forester C, Sartain S, Guo D, et al. Pediatric aplastic anemia and refractory cytopenia: A retrospective analysis assessing outcomes and histomorphologic predictors. Am J Hematol. 2015;90(4):320-326.